EOLS · Evolus Inc
United States · RS rating 85 · As of 2026-10-14
| Price | 7.22 USD |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 85 / 26 / 93 / 75 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 48 / 59 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | +100.0% |
| Sales growth Q/Q | +30.9% |
| Distance from 52-week high | +22.4% |
| Market cap (USD) | $345.5M |